( July 16, 2026, 2:58 PM EDT) -- NEW YORK — A Second Circuit U.S. Court of Appeals panel on July 15 affirmed a New York federal judge’s denial of a plaintiff-appellant biopharmaceutical company’s motion to vacate or modify a $16.5 million arbitral award in a licensing dispute over an expired patent covering a multiple sclerosis drug; the panel said the plaintiff-appellant “slept on its right” by voluntarily making postexpiration payments to the patent holder....